• News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
BW Businessworld

What Pharma Sector Is Looking Forward To The Year 2018‘

The Government under the Make in India initiative should promote more of R&D in the India Pharmaceutical Market

Photo Credit :


The Pharmaceutical sector has undergone rapid changes in the recent times and one of the recent decisions by the Government to promote e-pharmacies is a matter of concern, the decision if implemented can lead to the following:

Wrong Medication – General public is not qualified to understand the various signs and symptoms of a disease. Many are also confusing. e-pharmacies will increase self-medication which in turn will lead to late diagnosis of diseases.

Drug Abuse – We are all aware that how many drugs can be misused and abuse. e-pharmacies if not will lead to increase of such incidences. Also drugs are classified under various Schedules which should be restricted for use. Such medicines should never be allowed to be sold through e-pharmacies.

Less Control – Retails Drug stores are governed by the State Pharmacy Councils and FDAs which keep a check on the stores and ensure all rules & regulations are being implemented. They also help in prevention of drug abuse.

Temperature Control–Many of the biological drugs require special temperature for storage and transportation. Drugs dispatched through e-pharmacies would face such problem of temperature which would make the drug inactive.

Patient Counselling – A major role of the pharmacists is patient counselling. Many drugs have special precautions to be followed while they being consumed. E-pharmacies will be devoid of such benefits.

Unemployment – with more than 850,000 retails pharmacy stores in India, e-pharmacies can lead to unemployment, as each store is managed by 3-4 people on an average and e-pharmacies can be managed by 1 or 2 persons.

Having said about the above problems, I feel that in the coming years the Government should consider having  a 360 degree view while drafting the various policies. Whenever a policy is being drafted it should take into consideration all stake holders like the trade unions, manufacturers, API providers and off the customer as this will lead to a more robust policy which would benefit the overall pharmaceutical sector in India.

A strong policy would help us compete in the International markets. The Government under the Make in India initiative should promote more of R&D in the India Pharmaceutical Market. The sector also needs a strong policy to promote and boostAPI manufacturer so that we can compete against the foreign suppliers especially from China.

Disclaimer: The views expressed in the article above are those of the authors' and do not necessarily represent or reflect the views of this publishing house. Unless otherwise noted, the author is writing in his/her personal capacity. They are not intended and should not be thought to represent official ideas, attitudes, or policies of any agency or institution.

Tags assigned to this article:
pharmaceutical Year End 2017 opinion

Rahul Darda

The author is Chairman & Managing Director, Brinton Pharmaceuticals

More From The Author >>

Top themes and market attention on: